Status
Conditions
Treatments
About
Thirteen hospitals in China will participate in the study, which aims to provide data on serum bilirubin levels in the first 168 hr after birth in term and late-preterm neonates, and estimate the incidence of severe neonatal hyperbilirubinemia and the underlying causes.
We hypothesize that the study can be value in identifying and implementing strategies for risk reduction.
Full description
Neonatal hyperbilirubinemia resulting in clinical jaundice is a common problem among infants, particularly during the first weeks of life.
Information about the incidence and risk factors of neonatal jaundice is not available from China where is one of the highest countries of the incidence of severe neonatal hyperbilirubinemia.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Term or late-preterm newborn infants with GAs of ≥35 weeks and birth weights of ≥2,000 g were included.
Exclusion criteria
All sick newborn infants who were admitted to the intensive care unit.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal